Literature DB >> 26341295

Quantification of epicardial and intrathoracic fat volume does not provide an added prognostic value as an adjunct to coronary artery calcium score and myocardial perfusion single-photon emission computed tomography.

Mathias Possner1, Riccardo Liga1, Thomas Gaisl2, Jan Vontobel1, Olivier F Clerc1, Fran Mikulicic1, Dominik C Benz1, Christoph Gräni1, Julia Stehli1, Tobias A Fuchs1, Damini Dey3, Aju P Pazhenkottil1, Bernhard A Herzog1, Oliver Gaemperli1, Ronny R Buechel1, Philipp A Kaufmann4.   

Abstract

AIMS: To compare the predictive value of epicardial and intrathoracic fat volume (EFV, IFV), coronary artery calcium (CAC) score, and single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for major adverse cardiac events (MACE). METHODS AND
RESULTS: Follow-up was obtained in 275 patients with known or suspected coronary artery disease (CAD), who underwent SPECT-MPI including non-contrast cardiac computed tomography (CT) for attenuation correction to evaluate ischaemic heart disease and in whom EFV, IFV, and CAC score were calculated from non-contrast CT. Associations between fat volume, traditional cardiovascular risk factors, CAC score, and SPECT-MPI results were assessed and MACE predictors identified by Cox proportional hazard regression and global χ(2) statistics. After a median follow-up of 2.9 years, MACE were recorded in 38 patients. In univariate Cox regression analysis, EFV and IFV were predictors of MACE (P = 0.013 and P = 0.004, respectively). In multivariate analysis, EFV and IFV provided incremental predictive value beyond traditional cardiovascular risk factors (P < 0.05 and P < 0.01). However, after adjustment for CAC score and SPECT-MPI results, EFV and IFV fell short of statistical significance as independent outcome predictors.
CONCLUSION: Quantification of EFV and IFV is associated with MACE and may improve risk stratification beyond traditional cardiovascular risk factors. However, once CAC score and/or SPECT-MPI results are known, EFV and IFV do not provide any added clinically relevant prognostic value. Further studies may identify the subpopulation with the largest relative merit of EFV and IFV as an adjunct to SPECT-MPI and CAC score. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  coronary artery calcium score; epicardial fat volume; intrathoracic fat volume; major adverse cardiac events; myocardial perfusion imaging; outcome

Mesh:

Year:  2015        PMID: 26341295     DOI: 10.1093/ehjci/jev209

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

Review 1.  Addressing Knowledge Gaps in the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a Review of Recent Coronary Artery Calcium Literature.

Authors:  Vasanth Sathiyakumar; Roger S Blumenthal; Khurram Nasir; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

2.  Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality.

Authors:  Luiz Sérgio F de Carvalho; Thiago Quinaglia Ac Silva; Otávio Rizzi Coelho-Filho
Journal:  Arq Bras Cardiol       Date:  2018-12       Impact factor: 2.000

3.  Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.

Authors:  Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2019-08-30       Impact factor: 9.951

Review 4.  Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.

Authors:  William B Horton; Eugene J Barrett
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

5.  Epicardial Adipose Tissue Contributes to the Development of Non-Calcified Coronary Plaque: A 5-Year Computed Tomography Follow-up Study.

Authors:  In-Chang Hwang; Hyo Eun Park; Su-Yeon Choi
Journal:  J Atheroscler Thromb       Date:  2016-08-09       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.